BETA: Please send your feedback!

Zogenix

NAS:ZGNX

Pharmaceuticals: Other

$2.05bn
SMALL cap
$48.96 (2.30%)
28.3355%
since start of 2019
  • 2
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data Privacy
  • Consumer Health
  • Employee Satisfaction
  • Workplace Safety
  • Corp Gov
  • Ethical Practices
  • Conflict Materials
  • Forced Labor
  • Gender Diversity
  • 2
  • CF
  • PP
  • WC
  • DP
  • CH
  • ES
  • WS
  • CG
  • EP
  • CM
  • FL
  • GD
  • 1
  • 2
  • 3
  • 4
  • 5

About

Zogenix, Inc. is a pharmaceutical company, which engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. It develops two products candidate: ZX008 and Relday. The company was founded by Stephen J. Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA.
website

Headquarters

5858 Horton Street
Suite 455
Emeryville, CA 94608

Executives

Name Title Gender
Cam L. Garner, MBA Chairman Male
Roger L. Hawley, CPA Director Male
Scott L. Glenn Founder Male
John J. Turanin, MBA Founder Male
Bret E. Megargel, MBA Founder Male
Jonathan M. N. Rigby, MBA Founder Male
Michael P. Smith, MBA CFO, Secretary, Treasurer & Executive VP Male
Stephen J. Farr, PhD President, Chief Executive Officer & Director Male
Edward F. Smith, III, PhD Vice President-Regulatory Affairs & Drug Safety Male
Bradley S. Galer, MD Chief Medical Officer & Executive Vice President Male

Mindful Investing Summary

  • 1
  • 2
  • 3
  • 4
  • 5
  • Carbon Footprint N/A
  • Pollution Prevention N/A
  • Water Conservation N/A
  • Data & Privacy Protection N/A
  • Consumer Health, Wellness & Safety N/A
  • Employee Ownership, Satisfaction, Benefits & Pay N/A
  • Workplace Health and Safety N/A
  • Integrity of Corporate Governance N/A
  • Ethical Practices N/A
  • Usage of Conflict Materials N/A
  • Forced Labor N/A
  • Diversity of Corporate Leadership 2

Zogenix - Competitors and Related Companies

How Zogenix stacks up to its peers in the Pharmaceuticals: Other industry or with competing business segments.

Zogenix

NAS:ZGNX

Pharmaceuticals: Other

$2.05bn
SMALL cap
$48.96 (2.30%)
28.3355%
since start of 2019
  • 2
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data Privacy
  • Consumer Health
  • Employee Satisfaction
  • Workplace Safety
  • Corp Gov
  • Ethical Practices
  • Conflict Materials
  • Forced Labor
  • Gender Diversity
  • 2
  • CF
  • PP
  • WC
  • DP
  • CH
  • ES
  • WS
  • CG
  • EP
  • CM
  • FL
  • GD
  • 1
  • 2
  • 3
  • 4
  • 5
Loading…